IKK-β links inflammation to obesity-induced insulin resistance
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Inflammation may underlie the metabolic disorders of insulin resistance and type 2 diabetes. IkappaB kinase beta (IKK-beta, encoded by Ikbkb) is a central coordinator of inflammatory responses through activation of NF-kappaB. To understand the role of IKK-beta in insulin resistance, we used mice lacking this enzyme in hepatocytes (Ikbkb(Deltahep)) or myeloid cells (Ikbkb(Deltamye)). Ikbkb(Deltahep) mice retain liver insulin responsiveness, but develop insulin resistance in muscle and fat in response to high fat diet, obesity or aging. In contrast, Ikbkb(Deltamye) mice retain global insulin sensitivity and are protected from insulin resistance. Thus, IKK-beta acts locally in liver and systemically in myeloid cells, where NF-kappaB activation induces inflammatory mediators that cause insulin resistance. These findings demonstrate the importance of liver cell IKK-beta in hepatic insulin resistance and the central role of myeloid cells in development of systemic insulin resistance. We suggest that inhibition of IKK-beta, especially in myeloid cells, may be used to treat insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“failure to effectively resolve inflammation leading to a chronic state of inflammation is associated with IR/T2D and obesity [79,143].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [143]
In the citing paper
“Along these lines, numerous insulin-resistant states (e.g., obesity, type 2 diabetes, and lipid/heparin infusion) are associated with increased activation of JNK (18,21) and/or IKK (21)(22)(23)(24)(25) in parallel with inhibitory serine phosphorylation of IRS-1 (18,21).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [24]
In the citing paper
“In contrast, inhibition or inactivation of JNK (18,26) or IKK (22,24,25,27) improves insulin sensitivity in various models of insulin resistance in association with reduced inhibitory serine phosphorylation of IRS-1 (18).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [24]
In the citing paper
“Accordingly, KO or inhibition of JNK1 or IKKβ prevents insulin resistance in cell and mouse models (18,22,24,25,87) as well as human models (27) of insulin resistance.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [24]
In the citing paper
“The results showed that myeloid cell KO of IKKβ or JNK1 protected mice from HFD-induced glucose intolerance, hyperinsulinemia, and insulin resistance in skeletal muscle, adipose tissue, and the liver (24,87).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [24]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · cited 1×
“to quantify these functions in two separate models: Ikbkb Δhep mice on HFD and Ikbkb Δhep mice rendered homozygous for the ob mutation, causing leptin deficienc”
MethodObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In addition, many of the genes upregulated within fat during obesity are expressed in macrophage”
BackgroundXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Indeed, it was suggested that chronic inflammation contributes to obesity-induced insulin resistance through macrophage infiltration of fat depot”
BackgroundGlobal and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“, has increased considerably in recent years, reaching epidemic proportion”
BackgroundNuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Self-citationNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Self-citationObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Self-citationLocal and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Research works printed but not linked: 1
- Maeda, S. et al. IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 19, 725–737 (2003). · DOI · Paper page
Cited by
Items 901–1,000 of 1,004
Dynamic Interplay Between Metabolic Syndrome and Immunity
Paragh, G., Seres, I., Harangi, M., & Fülöp, P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_13 · Cited by 47
Goel, R., Boylan, B., Gruman, L. M., Newman, P. J., North, P. E., & Newman, D. K. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00157.2007 · Cited by 46
“This finding is consistent with previous studies, which showed that the atherogenic diet, in general, leads to a state of chronic, subacute inflammation (4, 8, 19).”
ResultIwamura, Y., Mori, M., Nakashima, K., Mikami, T., Murayama, K., Arai, S., & Miyazaki, T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.018 · Cited by 44
Molecular and Signaling Mechanisms of Atherosclerosis in Insulin Resistance
Schwartz, E. A., & Reaven, P. D. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.06.005 · Cited by 40
Passos, E., Ascensão, A. A. M. R., Martins, M. J., & Magalhães, J. (2015) · Metabolism · doi:10.1016/j.metabol.2015.02.003 · Cited by 42
Adipose tissue macrophages: the inflammatory link between obesity and cancer?
Wagner, M., Steinskog, E. S. S., & Wiig, H. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.991311 · Cited by 42
Passeri, E., Benedini, S., Costa, E., & Corbetta, S. (2015) · International Journal of Endocrinology · doi:10.1155/2015/352858 · Cited by 39
Steatosis and Steatohepatitis: Complex Disorders
Bettermann, K., Hohensee, T., & Haybaeck, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069924 · Cited by 48
“with high fat diet (HFD) [113–115].”
Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction
Cruz, V. H., Arner, E. N., Wynne, K. W., Scherer, P. E., & Brekken, R. A. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.007 · Cited by 41
“In a similar vein, myeloid cell specific knockout of Ikbkb (IKKb gene) in HFD fed mice resulted in improved insulin resistance and lower adiposity, supporting the central contribution of myeloid cells in the development of systemic insulin resistance [7].”
Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes
Sima, C., Paster, B. J., & Dyke, T. E. V. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026750 · Cited by 45
Cimini, F. A., Barchetta, I., Ciccarelli, G., Leonetti, F., Silecchia, G., Chiappetta, C., Cristofano, C. D., Capoccia, D., Bertoccini, L., Ceccarelli, V., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3358 · Cited by 43
Advances in T Cells Based on Inflammation in Metabolic Diseases
Yu, W., Li, C., Zhang, D., Li, Z., Xia, P., Liu, X., Cai, X., Yang, P., Ling, J., Zhang, J., et al. (2022) · Cells · doi:10.3390/cells11223554 · Cited by 44
“Studies have shown that obese mice dev loped insuli resistance in muscle and fat by blocking part of the NF-κB and Ju N-terminal kinase (JNK) pathways, which is attributed to the suppression of inflammatory signals [41,42].”
BackgroundSelf-citationHypothalamic inflammation and the central nervous system control of energy homeostasis
Pimentel, G. D., Ganeshan, K., & Carvalheira, J. B. C. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.005 · Cited by 48
“Not surprisingly, these newly recruited inflammatory immune cells up-regulate and increase the activity of a surfeit of proinflammatory signaling molecules such as, inhibitor of nuclear factor kappa-B kinase subunit beta (IKKb) (Lumeng et al., 2007; Cai et al., 2005; Arkan et al., 2005), IKKe, janus kinase (JNK) (Soli…”
BackgroundS-glutathionylation: relevance in diabetes and potential role as a biomarker
Sánchez-Gómez, F. J., Espinosa‐Díez, C., Dubey, M., Dikshit, M., & Lamas, S. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0150 · Cited by 42
“Downstream of Akt is the inhibitor of the nuclear factor kappa-B kinase β subunit (IKK β ), whose regulation is a main event in insulin resistance in diabetes (Arkan et al., 2005).”
BackgroundThe involvement of NLRX1 and NLRP3 in the development of nonalcoholic steatohepatitis in mice
Wang, Y., Fang, W., Wei, J., Wang, T., Wang, N., Ma, J., & Shi, M. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2013.08.010 · Cited by 42
Phosphodiesterase 3B (PDE3B) regulates NLRP3 inflammasome in adipose tissue
Ahmad, F., Chung, Y. W., Tang, Y., Hockman, S. C., Liu, S., Khan, Y., Huo, K., Billings, E. M., Amar, M. J., Remaley, A. T., et al. (2016) · Scientific Reports · doi:10.1038/srep28056 · Cited by 40
Liu, Y., Ge, X., Dou, X., Guo, L., Liu, Y., Zhou, S.-R., Wei, X.-B., Qian, S.-W., Huang, H.-Y., Xu, C.-J., et al. (2015) · Diabetes · doi:10.2337/db15-0278 · Cited by 41
Munkonda, M. N., Lapointe, M., Miegueu, P., Roy, C., Gauvreau, D., Richard, D., & Cianflone, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046883 · Cited by 38
Transcriptional control of macrophage polarisation in type 2 diabetes
Drareni, K., Gautier, J., Venteclef, N., & Alzaïd, F. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00748-1 · Cited by 40
Probiotic mediated NF-κB regulation for prospective management of type 2 diabetes
Bhardwaj, R., Singh, B. P., Sandhu, N., Singh, N., Kaur, R., Rokana, N., Singh, K. S., Chaudhary, V., & Panwar, H. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05254-4 · Cited by 40
Immunomodulation at epithelial sites by obesity and metabolic disease
Cheung, K. P., Taylor, K. R., & Jameson, J. (2011) · Immunologic Research · doi:10.1007/s12026-011-8261-7 · Cited by 42
Tamboli, R. A., Hajri, T., Jiang, A., Marks-Shulman, P. A., Williams, D. B., Clements, R. H., Melvin, W., Bowen, B. P., Shyr, Y., Abumrad, N. N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028577 · Cited by 37
Kiràly, M. A., Campbell, J. E., Park, E., Bates, H. E., Yue, J. T. Y., Rao, V., Matthews, S. G., Bikopoulos, G. J., Rozakis-Adcock, M., Giacca, A., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90575.2008 · Cited by 42
“Other serine kinases, such as PKC and IKK , are implicated in the mechanisms of hepatic insulin resistance (5, 13, 15, 53, 73, 74, 77).”
BackgroundRole of visceral fat in colonic inflammation: from Crohn's disease to diverticulitis
Paeschke, A., Erben, U., Kredel, L. I., Kühl, A. A., & Siegmund, B. (2016) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000324 · Cited by 42
Role of NO/VASP Signaling Pathway against Obesity-Related Inflammation and Insulin Resistance
Kang, Y. M., Kim, F., & Lee, W. J. (2017) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.41.2.89 · Cited by 41
Vitamin D deficiency enhances insulin resistance by promoting inflammation in type 2 diabetes.
Wang, W., Zhang, J., Wang, H., Wang, X., & Liu, S. (2019) · Europe PMC (PubMed Central) · Cited by 48
Treating insulin resistance: future prospects
Bailey, C. J. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.002 · Cited by 38
Sourris, K. C., Lyons, J. G., de Courten, M. P. J., Dougherty, S. L., Henstridge, D. C., Cooper, M. E., Hage, M., Dart, A., Kingwell, B. A., Forbes, J. M., et al. (2009) · Diabetes · doi:10.2337/db08-1725 · Cited by 38
Salicylates Increase Insulin Secretion in Healthy Obese Subjects
Fernández‐Real, J. M., López‐Bermejo, A., Ropero, A. B., Piquer, S., Nadal, Á., Bassols, J., Casamitjana, R., Gomis, R., Arnáiz, E., Pérez, I., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1212 · Cited by 42
You, P., Fu, S., Yu, K., Xia, Y., Wu, H., Yang, Y., Ma, C., Liu, D., Chen, X., Wang, J., et al. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1503-7 · Cited by 38
“As the upstream kinase for IκB, activated IKK phosphorylates IκB resulting in ubiquitination and degradation (Arkan et al. 2005).”
The Characteristics, Mechanisms and Therapeutics: Exploring the Role of Gut Microbiota in Obesity
Zhuang, Z., Zhou, P., Wang, J., Lu, X., & Chen, Y. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s432344 · Cited by 38
Common biological mechanisms between bipolar disorder and type 2 diabetes: Focus on inflammation
Sharma, A. N., Bauer, I. E., Sanches, M., Galvez, J. F., Zunta‐Soares, G. B., Quevedo, J., Kapczinski, F. P., & Soares, J. C. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.06.005 · Cited by 38
“Various labs also investigated the association of inflammatory pathways like NF-κB, IKKβ, and JNK with insulin resistance (Arkan et al., 2005; Cai et al., 2005; Shoelson et al., 2007).”
BackgroundPDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr Mice
Zhai, J., Zhang, Z.-X., Feng, Y., Ding, S., Wang, X., Zou, L., & Dong-qing, Y. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1501-7 · Cited by 37
UNIVERSIDADE DO EXTREMO SUL CATARINENSE - UNESC
Saúde, U. A. D., & Rosa, J. L. N. D. (2011) · Cited by 36
PCAF fine‐tunes hepatic metabolic syndrome, inflammatory disease, and cancer
Wang, T., Yao, W., Shao, Y., Zheng, R., & Huang, F. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13877 · Cited by 37
Pancreatic islet dysfunction in type 2 diabetes mellitus
Hu, F., Qiu, X., & Bu, S. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1510967 · Cited by 38
“By activating stress-related protein kinases, such as JNK-1, TNFa damages adipocytes and hepatocytes (Arkan et al. 2005, Tarantino and Caputi 2011).”
BackgroundNOD1: An Interface Between Innate Immunity and Insulin Resistance
RIVERS, S. L., Klip, A., & Giacca, A. (2019) · Endocrinology · doi:10.1210/en.2018-01061 · Cited by 40
Gao, F., Shen, J., Zhao, L., Hao, Q., & Yang, Y. (2019) · Medical Science Monitor · doi:10.12659/msm.918237 · Cited by 42
Recent Advances in Understanding the Role of IKKβ in Cardiometabolic Diseases
Hernandez, R., & Zhou, C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.752337 · Cited by 41
“Increased expression of circulating IL-6 (51) Hepatocytes Overexpression Improved insulin sensitivity; improved glucose homeostasis 1.”
BackgroundInfluentialEdible Bird’s Nest Prevents High Fat Diet-Induced Insulin Resistance in Rats
Zhang, Y., Imam, M. U., Ismail, M., Ooi, D. J., Sarega, N., Azmi, N. H., Ismail, N., Chan, K. W., Hou, Z., & Yusuf, N. B. (2015) · Journal of Diabetes Research · doi:10.1155/2015/760535 · Cited by 43
Novel roles for JNK1 in metabolism
Belgardt, B., Mauer, J., & Brüning, J. C. (2010) · Aging · doi:10.18632/aging.100192 · Cited by 39
Interleukin-Targeted Therapy for Metabolic Syndrome and Type 2 Diabetes
Maedler, K., Dharmadhikari, G., Schumann, D., & Størling, J. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_11 · Cited by 43
Association of Common Genetic Variants in the MAP4K4 Locus with Prediabetic Traits in Humans
Sartorius, T., Staiger, H., Ketterer, C., Heni, M., Machicao, F. E., Guilherme, A., Grallert, H., Schulze, M. B., Boeing, H., Stefan, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047647 · Cited by 36
Systemic Effects of White Adipose Tissue Dysregulation and Obesity‐Related Inflammation
Guri, A. J., & Bassaganya-Riera, J. (2011) · Obesity · doi:10.1038/oby.2010.230 · Cited by 43
“Likewise, mice deficient in hepatocyte IKKβ are immune from hepatic, though not systemic, IR (72).”
BackgroundFaghihimani, E., Aminorroaya, A., Rezvanian, H., Adibi, P., Ismail‐Beigi, F., & Amini, M. (2012) · Endocrine Practice · doi:10.4158/ep12064.or · Cited by 37
Ngabea, M. A., & Dimeji, I. Y. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152822 · Cited by 35
Is vitamin D deficiency an independent risk factor for obesity and abdominal obesity in women?
Tamer, G. I., Mesçi, B., Tamer, İ., Kılıç, D. Ç., & Arik, S. (2012) · PubMed · Cited by 47
Polyactives: controlled and sustained bioactive release via hydrolytic degradation
Stebbins, N. D., Faig, J. J., Yu, W., Guliyev, R., & Uhrich, K. E. (2015) · Biomaterials Science · doi:10.1039/c5bm00051c · Cited by 38
Mangge, H., Almer, G., Haj‐Yahya, S., Grandits, N., Gasser, R. N. A., Pilz, S., Möller, R., & Horejsi, R. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.013 · Cited by 35
“Mice lacking IKK in myeloid cells are protected from insulin resistance [44].”
BackgroundPhosphorylation of the exocyst protein Exo84 by TBK1 promotes insulin-stimulated GLUT4 trafficking
Uhm, M., Bazuine, M., Zhao, P., Chiang, S.-H., Xiong, T., Karunanithi, S., Chang, L., & Saltiel, A. R. (2017) · Science Signaling · doi:10.1126/scisignal.aah5085 · Cited by 35
Diet Composition for the Management of Obesity and Obesity-related Disorders
Botchlett, R. E., & Wu, C. (2018) · Journal of Diabetes Mellitus and Metabolic Syndrome · doi:10.28967/jdmms.2018.01.18002 · Cited by 44
“unsaturated fat [25, 26] primarily through its potent ability to activate multiple inflammatory mechanisms including macrophage infiltration and/or proinflammatory activation, and the c-Jun-N terminal kinase and TLR4 signaling pathways [22, 23, 27, 28] .”
BackgroundHeck, T. G., Ludwig, M. S., Frizzo, M. N., Rasia‐Filho, A. A., & de Bittencourt, P. I. H. (2020) · Clinical Science · doi:10.1042/cs20200596 · Cited by 40
ANT2 drives proinflammatory macrophage activation in obesity
Moon, J.-S., da Cunha, F. F., Huh, J. Y., Andreyev, A. Y., Lee, J., Mahata, S. K., Reis, F. C. G., Nasamran, C. A., & Lee, Y. S. (2021) · JCI Insight · doi:10.1172/jci.insight.147033 · Cited by 39
Huh, J. Y., & Saltiel, A. R. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00712-w · Cited by 41
Adipocyte-Secreted IL-6 Sensitizes Macrophages to IL-4 Signaling
Luan, D., Dadpey, B., Zaid, J., Bridge-Comer, P. E., DeLuca, J. H., Xia, W., Castle, J., & Reilly, S. M. (2022) · Diabetes · doi:10.2337/db22-0444 · Cited by 36
Pereira, S. S., Teixeira, L. G., Aguilar, E. C., Matoso, R. D. O., Soares, F. L. P., Ferreira, A. V. M., & Alvarez-Leite, J. I. (2011) · Animal Science Journal · doi:10.1111/j.1740-0929.2011.00982.x · Cited by 35
Chen, Y., Cheng, Y., Tzeng, C., Lee, Y., Chang, Y.-N., Lee, S.-C., Tsai, C.-C., Chen, J., Tzen, J. T. C., & Chang, S. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-30 · Cited by 35
Why do anti-inflammatory therapies fail to improve insulin sensitivity?
Gao, Z., & Ye, J. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.131 · Cited by 44
Co-culture with fat cells induces cellular insulin resistance in primary hepatocytes
Wang, Z., Lv, J., Zhang, R., Zhu, Y., Zhu, D., Sun, Y., Zhu, J., & Han, X. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.173 · Cited by 43
The immunology of sickness metabolism
Wensveen, F. M., Šestan, M., & Polić, B. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01192-4 · Cited by 38
An Easy, Convenient Cell and Tissue Extraction Protocol for Nuclear Magnetic Resonance Metabolomics
Mathéus, N., Hansen, S., Rozet, E., Peixoto, P., Maquoi, E., Lambert, V., Noël, A., Frédérich, M., Mottet, D., & Tullio, P. D. (2014) · Phytochemical Analysis · doi:10.1002/pca.2498 · Cited by 39
Zhou, M.-S., Liu, C., Tian, R., Nishiyama, A., & Raij, L. R. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0211-6 · Cited by 40
Increased Plasma Leptin in Antipsychotic-Naïve Females with Schizophrenia, but Not in Males
Wang, H. C., Yang, Y. K., Chen, P. S., Lee, I., Yeh, T. L., & Lu, R. (2007) · Neuropsychobiology · doi:10.1159/000122267 · Cited by 39
The macrophage at the intersection of immunity and metabolism in obesity
Samaan, M. C. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-29 · Cited by 39
Bernardes, N., Ayyappan, P., Angelis, K. D., Bagchi, A. K., Akolkar, G., Dias, D. D. S., Belló‐Klein, A., & Singal, P. K. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0663 · Cited by 39
“Indeed, ROS and endoplasmic reticulum stress can induce kappa B kinase beta to activate NF B, thereby stimulating the expression of many downstream pro-inflammatory cytokine gene targets (Arkan et al. 2005; Donath and Shoelson 2011).”
BackgroundHull, C. E., Dekeryte, R., Buchanan, H. M., Kamli-Salino, S., Robertson, A. A. B., Delibegović, M., & Platt, B. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108305 · Cited by 35
Guo, C., Liu, J., & Li, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110912 · Cited by 38
Greene, M. W., Ruhoff, M. S., Burrington, C. M., Garofalo, R. S., & Orena, S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.09.029 · Cited by 38
Hagman, D. K., Kuzma, J. N., Larson, I. A., Foster‐Schubert, K. E., Kuan, L.-Y., Cignarella, A., Geamanu, E. D., Makar, K. W., Gottlieb, J. R., & Kratz, M. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.08.018 · Cited by 43
Kasbi-Chadli, F., André, A., Prieur, X., Loirand, G., Meynier, A., Krempf, M., Nguyen, P., & Ouguerram, K. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511004387 · Cited by 49
Thomas, A. P., Dunn, T. N., Oort, P. J., Grino, M., & Adams, S. H. (2011) · Journal of Nutrition · doi:10.3945/jn.110.127068 · Cited by 40
Is NF-κB a culprit in type 2 diabetes?
Chen, F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.075 · Cited by 37
Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome
Erbay, E., Cao, H., & Hotamışlıgil, G. S. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0023-6 · Cited by 43
Kavitha, S. A., Zainab, S., Muthyalaiah, Y. S., John, C. M., & Arockiasamy, S. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10632-x · Cited by 41
“These ATMs exert inflammation through pathways involving IKKβ, TLR4, and JNK, also potentiating insulin resistance in mouse models [27–29].”
Obesity-associated digestive cancers: A review of mechanisms and interventions
Zheng, J., Zhao, M., Li, J., Lou, G., Yuan, Y., Bu, S., & Xi, Y. (2017) · Tumor Biology · doi:10.1177/1010428317695020 · Cited by 40
Ribes‐Navarro, A., Atef, M., Sánchez‐Sarasúa, S., Beltrán-Bretones, M. T., Olucha-Bordonau, F. E., & Sánchez‐Pérez, A. M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1091-z · Cited by 35
The Efficacy of Vitamin D Supplementation against Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Mansour‐Ghanaei, F., Pourmasoumi, M., Hadi, A., Ramezani‐Jolfaie, N., & Joukar, F. (2019) · Journal of Dietary Supplements · doi:10.1080/19390211.2019.1624671 · Cited by 35
“It regulates adipogenesis and inhibits NF-KB transcription, which is an important mediator between insulin resistance and hepatic inflammation (Arkan et al. 2005).”
BackgroundVorotnikov, A. V., Stafeev, I., Menshikov, M. Y., Shestakova, M. V., & Parfyonova, Y. V. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919110099 · Cited by 38
Biagioli, M., & Fiorucci, S. (2021) · Liver Research · doi:10.1016/j.livres.2021.08.003 · Cited by 37
REDD1 promotes obesity-induced metabolic dysfunction via atypical NF-κB activation
Lee, D., Kim, T., Byeon, J., Park, M., Kim, S., Kim, J., Choi, S., Lee, G., Park, C., Lee, K. W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34110-1 · Cited by 36
Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo
Pereira, S., Park, E., Moore, J., Faubert, B., Breen, D. M., Oprescu, A. I., Nahle, A., Kwan, D., Giacca, A., & Tsiani, E. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0075 · Cited by 37
Impacts of the apoptosis inhibitor of macrophage (AIM) on obesity-associated inflammatory diseases
Arai, S., & Miyazaki, T. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0405-5 · Cited by 36
Gao, Z., Zhang, J., Henagan, T. M., Lee, J. H., Ye, X., Wang, H., & Ye, J. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00532.2014 · Cited by 39
Targeting gp130 to prevent inflammation and promote insulin action
Kraakman, M. J., Allen, T. L., Whitham, M., Iliades, P., Kammoun, H. L., Estevez, E., Lancaster, G. I., & Febbraio, M. A. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12170 · Cited by 33
Cucak, H., Mayer, C., Tonnesen, M., Thomsen, L. H., Grunnet, L. G., & Rosendahl, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090685 · Cited by 36
Sugita, M., Sugita, H., Kim, M., Mao, J., Yasuda, Y., Habiro, M., Shinozaki, S., Yasuhara, S., Shimizu, N., Martyn, J. A. J., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.001 · Cited by 35
Diet‐induced obesity impairs AKT signalling in the retina and causes retinal degeneration
Marçal, A. C., Leonelli, M., Fiamoncini, J., Deschamps, F. C., Rodrigues, M. A. M., Curi, R., Carpinelli, Â. R., Britto, L. R. G., & Carvalho, C. R. D. O. (2012) · Cell Biochemistry and Function · doi:10.1002/cbf.2861 · Cited by 37
Reinisch, I., Michenthaler, H., Sulaj, A., Moyschewitz, E., Krstić, J., Galhuber, M., Xu, R., Riahi, Z., Wang, T., Vujić, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45724-y · Cited by 37
Stabilization and Augmentation of Circulating AIM in Mice by Synthesized IgM-Fc
Kai, T., Yamazaki, T., Arai, S., & Miyazaki, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097037 · Cited by 38
Reynolds, C. M., Li, M., Gray, C. L., & Vickers, M. H. (2013) · Endocrinology · doi:10.1210/en.2013-1146 · Cited by 33
Inflammasome activation and metabolic disease progression
Li, H., Jin, C., Chen, Y., & Flavell, R. A. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.020 · Cited by 35
Negative Regulators of Insulin Signaling Revealed in a Genome-Wide Functional Screen
Huang, S.-M. A., Hancock, M. K., Pitman, J. L., Orth, A. P., & Gekakis, N. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006871 · Cited by 38
The emerging biology of adipose tissue in chronic kidney disease: from fat to facts
Axelsson, J. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn376 · Cited by 36
“Another factor that may contribute to uraemic insulin resistance is inflammation, which is present in a large proportion of CKD patients [38] and may act through specific pathways such as SOCS [39] and IKK-β [40] to inhibit insulin signalling.”
BackgroundHelsley, R. N., Sui, Y., Park, S., Liu, Z., Lee, R. G., Zhu, B., Kern, P. A., & Zhou, C. (2016) · Stem Cells · doi:10.1002/stem.2358 · Cited by 39
Mandave, P. C., Khadke, S. P., Karandikar, M., Pandit, V. A., Ranjekar, P. K., Kuvalekar, A., & Mantri, N. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010124 · Cited by 45
“Administration of a specific inhibitor of IL1 signaling has been shown to ameliorate inflammation-induced hyperglycemia [59].”
BackgroundResultInfluentialAhmadnezhad, M., Arefhosseini, S. R., Parizadeh, M. R., Tavallaie, S., Tayefi, M., Darroudi, S., Ghazizadeh, H., Moohebati, M., Ebrahimi, M., Heidari‐Bakavoli, A., et al. (2018) · BioFactors · doi:10.1002/biof.1424 · Cited by 34
Amelioration of glucose tolerance by hepatic inhibition of nuclear factor κB in db/db mice
Tamura, Y., Ogihara, T., Uchida, T., Ikeda, F., Kumashiro, N., Nomiyama, T., Sato, F., Hirose, T., Tanaka, Y., Mochizuki, H., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0467-1 · Cited by 40
Microbiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetes
Lacerda, R. R. E., Fang, H., Robin, N., Bhatwa, A., Marko, D. M., & Schertzer, J. D. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.100610 · Cited by 41
Homoplantaginin Modulates Insulin Sensitivity in Endothelial Cells by Inhibiting Inflammation
Wu, F., Wang, H., Li, J., Liang, J., & Ma, S. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b110586 · Cited by 32
Ferro, A., Qu, W., Lukowicz, A., Svedberg, D., Johnson, A., & Cvetanovic, M. (2018) · PLOS ONE · doi:10.1371/journal.pone.0200013 · Cited by 26
Metadata
- Authors
- Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M.
- Affiliations
- University of California San Diego (US)
- Moffitt Cancer Center (US)
- Ospedale San Luigi Gonzaga (IT)
- Corresponding author
- Olefsky, Jerrold
- Karin, Michael
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-01-30
- Volume
- 11
- Issue
- 2
- Pages
- 191-198
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1991401793
- Cited by
- 1,773
- References
- 42
- Citations by year
- 2026: 23 · 2025: 41 · 2024: 47 · 2023: 50 · 2022: 64 · 2021: 54 · 2020: 74 · 2019: 77 · 2018: 83 · 2017: 69 · 2016: 82 · 2015: 100 · 2014: 113 · 2013: 129 · 2012: 123
- FWCI
- 67.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- National Institutes of Health
- University of California, San Diego
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 60484, DK-33651, K01DK060484)
- National Institute of Environmental Health Sciences (ES 06376, R01ES006376)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
- Keywords
- IKKβ, insulin resistance, obesity, inflammation, NF-κB, type 2 diabetes, hepatic insulin resistance, myeloid cells, high-fat diet, aging, skeletal muscle insulin sensitivity, adipose tissue insulin sensitivity
- MeSH terms
- Animals, Cells, Cultured, Dietary Fats, Glucose Tolerance Test, Inflammation, Insulin, Insulin Resistance, Obesity, Phenotype, Signal Transduction, Cytokines, NF-kappa B, Protein Serine-Threonine Kinases, Mice, Knockout, Myeloid Cells, Hepatocytes, Mice, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.